483
RK Pharma Inc.FDA 483 - RK Pharma Inc. - May 31, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
RK Pharma Inc. in Pearl River, NY, was inspected and received a Form 483 with five observations. The inspection revealed significant deficiencies in equipment qualification, cleaning validation, laboratory controls for visual inspection, data integrity for electronic audit trails, and record-keeping for rejected drug products. These issues indicate a lack of robust quality systems impacting the safety, identity, strength, quality, and purity of their drug products.
Open in Dashboard
ID · e37ee092-9fd9-4edf-93b7-2e81b4fb6f6b